Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

3.7K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
3.7K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

126
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
126
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

85
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
85
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

5.2K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
5.2K
Dose-Response Relationship: Selectivity and Specificity01:25

Dose-Response Relationship: Selectivity and Specificity

8.1K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
8.1K
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

198
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
198

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Semi-parametric testing for ordinal treatment effects in time-to-event data via dynamic Dirichlet process mixtures of the inverse-Gaussian distribution.

Statistical methods in medical research·2025
Same author

Extracellular Vesicle (EV) Mechanisms of Toxicity for Per and Polyfluoroalkyl Substances: Comparing Transcriptomic Points of Departure Across Global Versus EV Regulatory Gene Sets.

Environmental and molecular mutagenesis·2025
Same author

Bayesian gene set benchmark dose estimation for "omic" responses.

Bioinformatics (Oxford, England)·2025
Same author

The 2022 world health organization reevaluation of human and mammalian toxic equivalency factors for polychlorinated dioxins, dibenzofurans and biphenyls.

Regulatory toxicology and pharmacology : RTP·2023
Same author

A multi-tiered hierarchical Bayesian approach to derive toxic equivalency factors for dioxin-like compounds.

Regulatory toxicology and pharmacology : RTP·2023
Same author

Accelerating Colorectal Cancer Screening and Follow-up through Implementation Science (ACCSIS) in Appalachia: protocol for a group randomized, delayed intervention trial.

Translational behavioral medicine·2023
Same journal

High-dimensional multivariate geostatistics: A Bayesian matrix-normal approach.

Environmetrics·2026
Same journal

Bayesian Inference for Spatially-Temporally Misaligned Data Using Predictive Stacking.

Environmetrics·2026
Same journal

Spike and Slab Regression for Nonstationary Gaussian Linear Mixed Effects Modeling of Rapid Disease Progression.

Environmetrics·2026
Same journal

Semiparametric approaches for mitigating spatial confounding in large environmental epidemiology cohort studies.

Environmetrics·2025
Same journal

Penalized distributed lag interaction model: Air pollution, birth weight, and neighborhood vulnerability.

Environmetrics·2025
Same journal

Assessing predictability of environmental time series with statistical and machine learning models.

Environmetrics·2025
查看所有相关文章

相关实验视频

Updated: Sep 9, 2025

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation

Published on: September 4, 2017

15.9K

用于预测集群级剂量反应的层次约束密度回归模型

Michael L Pennell1, Matthew W Wheeler2, Scott S Auerbach3

  • 1Division of Biostatistics, College of Public Health, The Ohio State University, Columbus, Ohio, USA.

Environmetrics
|September 2, 2025
PubMed
概括
此摘要是机器生成的。

化学毒性查需要新的统计方法. 限制物流密度回归 (COLDER) 同时模拟基因表达数据,改进化学安全评估的转录组测试分析.

关键词:
贝叶斯非参数基准剂量剂量反应建模功能数据分析棒破碎过程毒基因组学

更多相关视频

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K

相关实验视频

Last Updated: Sep 9, 2025

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation

Published on: September 4, 2017

15.9K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K

科学领域:

  • 毒理学
  • 生物信息学
  • 统计模型

背景情况:

  • 转录组测试产生用于化学毒性查的大量数据集.
  • 目前的方法分析基因单独, 缺乏高暴露水平的灵活性.
  • 现有的方法无法在生物通道内在基因之间共享信息.

研究的目的:

  • 引入受约束物流密度回归 (COLDER) 用于同时建模基因表达数据.
  • 解决目前毒性查的统计方法的局限性.
  • 开发一种能够解释剂量反应形状变化的方法,并共享路径信息.

主要方法:

  • 拟议的受限制物流密度回归 (COLDER) 模型.
  • 使用离散物流断棒过程 (LSBP) 进行预先分配.
  • 纳入基因层面的特征 (例如,路径成员) 和生物可信的形状约束.
  • 基因通路内的基准剂量后部分布估计.

主要成果:

  • COLDER可以同时对多个基因的表达数据进行建模.
  • 这种方法允许基因在相同的途径中共享信息.
  • 可以直接估计基准剂量的后期分布.
  • 通过模拟和国家毒理学计划研究评估模型性能.

结论:

  • COLDER为分析高通量毒性数据提供了改进的统计方法.
  • 该方法增强了化学安全的大型转录组数据集的合成.
  • COLDER提供了更具生物可信性和信息性的剂量反应关系分析.